(63 days)
Not Found
No
The document mentions "image processing" and "adaptive image post-processing" but does not use terms like AI, ML, deep learning, neural networks, or describe any algorithms or training data typically associated with AI/ML. The focus is on standard MRI imaging techniques and hardware enhancements.
No
The device is described as an "imaging device" used to provide "physiological and clinical information" for "diagnosis determination," and its primary function is to produce images rather than to treat conditions.
Yes
The device is explicitly referred to as an "imaging device" and "Magnetic Resonance Diagnostic Devices" and states that "When interpreted by a trained physician, these images provide information that can be useful in diagnosis determination."
No
The device description explicitly states it is an "additional RF Coil (PA/QD Shoulder Coil)" which is a hardware component for an MRI system. While it mentions image processing, the core device being described and enhanced is a physical coil.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The description clearly states that this device is an MR system and an RF Coil used for imaging. It produces images of internal structures based on magnetic resonance properties.
- Intended Use: The intended use is for imaging and providing physiological and clinical information obtained non-invasively. It aids in diagnosis determination by providing images for interpretation by a physician.
- No Sample Analysis: There is no mention of analyzing samples taken from the body. The device interacts directly with the patient's body to generate images.
Therefore, the PA/QD Shoulder Coil and the associated MR system are imaging devices, not in vitro diagnostic devices.
N/A
Intended Use / Indications for Use
The PA/QD Shoulder Coil provides imaging of the shoulder articular anatomy and other large joints.
The MR system is an imaging device, and is intended to provide the physician with physiological and clinical information, obtained non-invasively and without the use of ionizing radiation. The MR system produces transverse, coronal, sagittal, oblique, and curved cross-sectional images that display the internal structure of the head, body, or extremities. The images produced by the MR system reflect the spatial distribution of protons (hydrogen nuclei) exhibiting magnetic resonance. The NMR properties that determine the image appearance are proton density, spin-lattice relaxation time (T1), spin-spin T2, and flow. When interpreted by a trained physician, these images provide relaxation time (T2), and flow. information that can be useful in diagnosis determination.
- Head, Body, Spine, Extremities Anatomical Region: Nucleus excited: Proton Diagnostic uses:
- Diagnostic uses:
2D T1- / T2-weighted imaging T1. T2, proton density measurements MR Angiography image processing
- Imaging capabilities:
- 2D, 3D Spin Echo (SE)
- 2D, 3D Fast Spin Echo (FSE)
- 2D Inversion Recovery (IR)
- 2D. 3D Fast Inversion Recovery (FIR)
- 2D,3D Gradient Echo (GE)
- 2D, 3D Steady state acquisition with rewinded GE (SARGE)
- 2D, 3D RF-spoiled SARGE (RSSG)
- 2D, 3D Time-reversed SARGE (TRSG)
MR Angiography (half echo, high resolution/high definition, sloped slab profile, magnetization transfer contrast)
- 2D, 3D TOF
- 2D, 3D TOF RSSG
- ECG, Peripheral Gating
- RF Coil Uniformity
Adaptive Image post-processing
ACR/NEMA/DICOM 3 compliant
- Aids in the performance of minimally invasive, diagnostic, and therapeutic procedures of the head, body and extremities which may be facilitated by real-time MR guidance. Such procedures must be performed with MRI-compatible instrumentation, as selected and evaluated by the clinical user.
Product codes (comma separated list FDA assigned to the subject device)
90LNH, 90MOS
Device Description
The AIRIS and AIRIS II MRI Magnetic Resonance Diagnostic Devices are being enhanced by one additional RF Coil (PA/QD Shoulder Coil) to increase the clinical utility of the AIRIS and AIRIS II in the stationary configuration. The Shoulder Coil can operate either in the quadrature mode or in the phased array mode with the AIRIS II, and in the quadrature mode only with the AIRIS. The coil is available in Large and Standard sizes for both MRI systems, to accommodate a wide variety of physical patient sizes, and to achieve maximal coil filling factors. Part numbering is as follows:
MRI System | Imaging Mode | Coil Size | Part Number |
---|---|---|---|
AIRIS II | Phased Array | Standard | MR-PSC-51 |
Phased Array | Large | MR-PSC-52 | |
Quadrature | Standard | MR-QSC-51 | |
Quadrature | Large | MR-QSC-52 | |
AIRIS | Quadrature | Standard | MR-QSC-51 |
Quadrature | Large | MR-QSC-51 |
AIRIS and AIRIS II software did not need to be revised in order to support full functionality of this PA/QD Shoulder Coil.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Magnetic Resonance (MR)
Anatomical Site
Head, Body, Spine, Extremities, Shoulder
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Trained physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1000 Magnetic resonance diagnostic device.
(a)
Identification. A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).(b)
Classification. Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
992650
OCT 8 1999
Attachment 1
510(k) Summary of Safety and Effectiveness
1
SUBMITTER INFORMATION: 1.0
| 1.1 | Submitter: | Hitachi Medical Systems America
1959 Summit Commerce Park
Twinsburg, OH 44087
PH: 330 425-1313
FX: 330 425-1410 |
|-----|-------------------------|-----------------------------------------------------------------------------------------------------------------------------|
| 1.2 | Contact: | James Jochen Rogers |
| 1.3 | Date: | August 5, 1999 |
| 2.0 | DEVICE NAME: | |
| 2.1 | Classification Panel: | Radiology |
| 2.2 | Classification Number: | 892.1000 Magnetic Resonance Diagnostic Device |
| 2.3 | Product Nomenclature: | System, Nuclear Magnetic Resonance Imaging |
| 2.4 | Product Code(s): | 90LNH
90MOS (Magnetic Resonance Specialty Coil) |
| 2.5 | Trade/Proprietary Name: | AIRIS, AIRIS II |
| 2.6 | PREDICATE DEVICE(s): | Hitachi AIRIS, AIRIS II |
DEVICE DESCRIPTION: 3.0
The AIRISand AIRIS II MRI Magnetic Resonance Diagnostic Devices are being enhanced by one additional RF Coil (PA/QD Shoulder Coil) to increase the clinical utility of the AIRIS and AIRIS II in the stationary configuration. The Shoulder Coil can operate either in the quadrature mode or in the phased array mode with the AIRIS II, and in the quadrature mode only with the AIRIS. The coil is available in Large and Standard sizes for both MRI systems, to accommodate a wide variety of physical patient sizes, and to achieve maximal coil filling factors. Part numbering is as follows:
MRI System | Imaging Mode | Coil Size | Part Number |
---|---|---|---|
AIRIS II | Phased Array | Standard | MR-PSC-51 |
Phased Array | Large | MR-PSC-52 | |
Quadrature | Standard | MR-QSC-51 | |
Quadrature | Large | MR-QSC-52 | |
AIRIS | Quadrature | Standard | MR-QSC-51 |
Quadrature | Large | MR-QSC-51 |
AIRIS and AIRIS II software did not need to be revised in order to support full functionality of this PA/QD Shoulder Coil.
2
SCIENTIFIC CONCEPTS 3.2
Magnetic Resonance (MR) is based on the fact that certain atomic nuclei have electromagnetic properties which cause them to act as small spinning bar magnets. The most ubiquitous of these nuclei is hydrogen, which makes it the primary nucleus used in current imaging experiments in magnetic resonance. When placed in a magnetic field, there is a slight net orientation or alignment of these atomic nuclei with the magnetic field. The introduction of a short burst of radiofrequency (RF) excitation of wavelength specific to the magnetic field strength and to the atomic nuclei under consideration can cause a reorientation of the proton's magnetization vector. When the RF excitation is removed, the proton relaxes and returns to its original orientation. The rate of relaxation is exponential, and varies with the character of the proton and its adjacent molecular environment. This reorientation process is characterized by two exponential relaxation times called T1 and T2 which can be measured.
These relaxation events are accompanied by an RF emission or echo which can be measured and used to develop a representation of these emissions on a three dimensional matrix. Spatial localization is encoded into the echo by varying the RF excitation and by appropriately applying magnetic field gradients in x, y, and z directions, and changing the direction and strength of these gradients. Images depicting the spatial distribution of NMR characteristics of the nuclei under consideration can be constructed by using image processing techniques similar to those used in CT.
For magnetic fields up to 1.5T. the RF frequencies commonly used range up to 65MHz. The RF fields have pulse powers from several watts to greater than 10 kilowatts, and repeat at rates from once every few seconds to greater than fifty per second. The timevarying magnetic gradient fields have a typical duration of sub-millisecond to several milliseconds.
3.3 PHYSICAL AND PERFORMANCE CHARACTERISTICS
MR is currently of great interest because it is capable of producing high quality anatomical images without the associated risks of ionizing radiation. In addition, the biological properties that contribute to MR image contrast are different from those responsible for x-ray image contrast. In x-ray imaging, differences in x-ray attenuation, largely based on differences in electro density are responsible for the contrast observed in x-ray images. In MR imaging, differences in proton density, blood flow, and relaxation times T1 and T2 all may contribute to image contrast. In addition, by varying the duration and spacing of the RF pulses, images may be produced in which the contrast is primarily dependent on T1 relaxation, T2 relaxation, proton density, or a combination of all three.
4.0 DEVICE INTENDED USE:
The MR system is an imaging device, and is intended to provide the physician with physiological and clinical information, obtained non-invasively and without the use of ionizing radiation. The MR system produces transverse, coronal, sagittal, oblique, and curved cross-sectional images that display the internal structure of the head, body, or extremities. The images produced by the MR system reflect the spatial distribution of protons (hydrogen nuclei) exhibiting magnetic resonance. The NMR properties that determine the image appearance are proton density, spin-lattice relaxation time (T1), spin-spin relaxation time (T2), and flow. When interpreted by a trained physician, these images provide information that can be useful in diagnosis determination.
3
- Head, Body, Spine, Extremities Anatomical Region:
- . Proton Nucleus excited:
- . Diagnostic uses:
- 2D T1- / T2-weighted imaging T1, T2, proton density measurements
- MR Angiography
- image processing
- · Imaging capabilities:
- 2D Spin Echo (SE); also with rephase
- 2D Gradient Field Echo (GE); also with rephase (2D GR)
- 2D Steady state acquisition with rewinded GE (SARGE);
- also with RF spoiling, rephasing
- 2D Inversion Recovery (IR)
- 2D Fast Spin Echo (FSE); also with rephase
- 2D Fast Inversion Recovery (FIR)
- 2D Dual Slice acquisition (SEDS)
- 3D Spin Echo (SE)
- 3D Gradient Field Echo (GE)
- 3D Steady state acquisition with rewinded GE (SARGE); also with RF spoiling, rephasing
- MR Angiography (2D TOF, 3D TOF, half echo, high resolution/high definition, sloped slab profile, magnetization transfer contrast)
- MR Fluoroscopy
- RF Coil Uniformity
- Adaptive Image post-processing
- ACR/NEMA/DICOM 3 compliant
- Aids in the performance of minimally invasive, diagnostic, and therapeutic procedures of the head, body, and extremities which may be facilitated by real-time MR guidance. Such procedures must be performed with MRI-compatible instrumentation, as selected and evaluated by the clinical user.
DEVICE TECHNOLOGICAL CHARACTERISTICS: 5.0
Identical to the Predicate Device.
4
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
OCT 8 1999
James Jochen Rogers Manager, Regulatory Affairs Hitachi Medical Systems America, Inc. 1959 Summit Commerce Park Twinsburg, Ohio 44087
Re:
K992650 PA/QD Shoulder Coil for Airis and Airis II Dated: August 5, 1999 Received: August 6, 1999 Regulatory class: II 21 CFR 892.1000/Procode: 90 MOS
Dear Mr. Rogers:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General requlation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Capt. Daniel G. Schultz, M.D.
Capt. Daniel G. Schultz, M.D. Acting Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
K992650 510(k) Number (if known): _
Device Name: Additional RF Coil for AIRIS, AIRIS II (PA/QD Shoulder Coil)
Indications for Use:
The PA/QD Shoulder Coil provides imaging of the shoulder articular anatomy and other large joints.
The MR system is an imaging device, and is intended to provide the physician with physiological and clinical information, obtained non-invasively and without the use of ionizing radiation. The MR system produces transverse, coronal, sagittal, oblique, and curved cross-sectional images that display the internal structure of the head, body, or extremities. The images produced by the MR system reflect the spatial distribution of protons (hydrogen nuclei) exhibiting magnetic resonance. The NMR properties that determine the image appearance are proton density, spin-lattice relaxation time (T1), spin-spin When interpreted by a trained physician, these images provide relaxation time (T2), and flow. information that can be useful in diagnosis determination.
- Head, Body, Spine, Extremities Anatomical Region: Nucleus excited: Proton Diagnostic uses:
- Diagnostic uses:
2D T1- / T2-weighted imaging T1. T2, proton density measurements MR Angiography image processing
- Imaging capabilities:
- 2D, 3D Spin Echo (SE)
- 2D, 3D Fast Spin Echo (FSE)
- 2D Inversion Recovery (IR)
- 2D. 3D Fast Inversion Recovery (FIR)
- 2D,3D Gradient Echo (GE)
- 2D, 3D Steady state acquisition with rewinded GE (SARGE)
- 2D, 3D RF-spoiled SARGE (RSSG)
- 2D, 3D Time-reversed SARGE (TRSG)
MR Angiography (half echo, high resolution/high definition, sloped slab profile, magnetization transfer contrast)
- 2D, 3D TOF
- 2D, 3D TOF RSSG
- ECG, Peripheral Gating
- RF Coil Uniformity
Adaptive Image post-processing
ACR/NEMA/DICOM 3 compliant
- Aids in the performance of minimally invasive, diagnostic, and therapeutic procedures of the head, body and extremities which may be facilitated by real-time MR guidance. Such procedures must be performed with MRI-compatible instrumentation, as selected and evaluated by the clinical user.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
(Per 21 CFR 801-109
OR Over-the-Counter Use
/ Semm
(Optional Format 1-2-96)
(Division Sign-Off)
Division of Reproductive, Abdominal, ENT,
and Radiological Devices
510(k) Number K992650
(Optional Format 1-2-96)